Effect of oral melatonin in controlling pruritus in patients with atopic dermatitis
Phase 3
Recruiting
- Conditions
- Atopic dermatitis.Atopic dermatitis
- Registration Number
- IRCT20120215009014N483
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 12 to 65 years
Atopic dermatitis
Exclusion Criteria
Pregnancy or breastfeeding
Liver, kidney, nervous or immune system disease
Use of warfarin and fluvoxamine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The intensity of itching. Timepoint: Before the intervention and then 2, 4 and 6 weeks after the intervention. Method of measurement: Using visual analog scale (VAS).;Severity of atopic dermatitis. Timepoint: Before the intervention and then 2, 4 and 6 weeks after the intervention. Method of measurement: Using the Scoring Atopic Dermatitis tool (SCORAD).
- Secondary Outcome Measures
Name Time Method